Delivra Health Brands Inc.
DHB.V
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 9.19M | 8.72M | 9.14M | 8.99M | 8.45M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 9.19M | 8.72M | 9.14M | 8.99M | 8.45M |
| Cost of Revenue | 4.61M | 4.26M | 4.42M | 4.12M | 4.01M |
| Gross Profit | 4.58M | 4.46M | 4.73M | 4.87M | 4.44M |
| SG&A Expenses | 4.75M | 4.53M | 4.28M | 4.04M | 3.94M |
| Depreciation & Amortization | 951.20K | 957.90K | 967.90K | 979.00K | 982.70K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.31M | 9.74M | 9.66M | 9.14M | 8.93M |
| Operating Income | -1.12M | -1.02M | -519.60K | -145.80K | -477.30K |
| Income Before Tax | 13.40K | 116.50K | 635.50K | -522.20K | -819.40K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 0.01 | 0.12 | 0.64 | -0.52 | -0.82 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 13.40K | 116.50K | 635.50K | -522.20K | -819.40K |
| EBIT | -1.12M | -1.02M | -519.60K | -145.80K | -477.30K |
| EBITDA | -168.00K | -57.00K | 452.00K | 831.90K | 504.80K |
| EPS Basic | 0.00 | 0.00 | 0.02 | -0.02 | -0.03 |
| Normalized Basic EPS | -0.03 | -0.03 | -0.02 | -0.03 | -0.04 |
| EPS Diluted | 0.00 | 0.00 | 0.02 | -0.02 | -0.03 |
| Normalized Diluted EPS | -0.03 | -0.03 | -0.01 | -0.03 | -0.04 |
| Average Basic Shares Outstanding | 123.84M | 119.09M | 114.29M | 108.30M | 102.30M |
| Average Diluted Shares Outstanding | 134.61M | 129.87M | 125.07M | 119.08M | 102.30M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |